Patents Assigned to Prolx Pharmaceuticals Corporation
  • Inhibitors of redox signaling and methods of using same
    Patent number: 6372772
    Abstract: The present invention is directed to a composition or formulation which inhibits or interferes with cellular redox function, and method of using same to restore normal cellular function. More specifically, the composition of the present invention interferes with or inhibits abnormal cellular proliferation and//restores or cellular apoptosis.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: April 16, 2002
    Assignee: Prolx Pharmaceuticals Corporation
    Inventors: D. Lynn Kirkpatrick, Garth Powis